Related Experiment Video
Updated: Apr 21, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
Published on: July 22, 2025
Artificial intelligence-based prognostic models in acute myeloid leukemia: systematic review and meta-analysis
Xiaoyi Zhang1, Na Xiao2, Simo Du1
1Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY.
Artificial intelligence (AI) models for acute myeloid leukemia (AML) survival prediction show moderate accuracy but significant variability. Further validation is needed for these machine learning tools.
Area of Science:
- Hematology
- Medical Informatics
- Biostatistics
Background:
- Machine learning (ML) and deep learning (DL) show promise for improving survival prediction in acute myeloid leukemia (AML).
- Comparative benchmarks for artificial intelligence (AI)-based survival prediction models in AML are not well-established.
- Existing studies often lack standardized reporting and rigorous external validation.
Purpose of the Study:
- To systematically review and meta-analyze the performance of AI models for overall survival (OS) and relapse-free survival (RFS) prediction in AML.
- To compare the performance of gene-centric versus nongenetic AI models.
- To assess the risk of bias and optimism bias in AML survival prediction models.
Main Methods:
- Systematic literature search using PRISMA 2020 guidelines (PubMed, Scopus, Web of Science, January 2018-March 2025).
- Inclusion of studies developing or externally validating AI models for AML survival prediction, reporting Area Under the Receiver Operating Characteristic Curve (AUC).
- Data extraction on study design, population, features, algorithms, and AUCs; risk of bias assessment using PROBAST; random-effects meta-analysis.
Main Results:
- Included 24 studies (137 model cohorts, ~51,055 patients); 74% had low risk of bias, with statistical analysis being the weakest domain.
- Pooled validation AUC across 73 independent cohorts was 0.769 (95% CI, 0.742-0.795), with substantial heterogeneity (I² = 95.7%).
- Validation AUCs increased with prediction horizon (5-year AUC = 0.833). Nongenetic models showed a trend towards higher AUC (0.776) than gene-centric models (0.741).
Conclusions:
- AI prognostic models for AML demonstrate moderate discrimination with modest optimism bias but significant heterogeneity.
- Limited prospective validation necessitates standardized reporting and rigorous external evaluation of these models.
- Performance varies by prediction horizon and feature type, highlighting the need for careful model selection and validation.
More Related Videos
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025